Page 18 - IMO-2-3
P. 18
Innovative Medicines & Omics MSC exosomes for digestive tumors: Bench to bedside
Annu Rev Pathol. 2022;18:123-148. disorders. J Extracell Vesicles. 2023;12:e12361.
doi: 10.1146/annurev-pathmechdis-031621-024600 doi: 10.1002/jev2.12361
55. Kumarasamy V, Wang J, Frangou C, et al. The extracellular 64. Levy D, Jeyaram A, Born LJ, et al. Impact of storage
niche and tumor microenvironment enhance KRAS conditions and duration on function of native and cargo-
inhibitor efficacy in pancreatic cancer. Cancer Res. loaded mesenchymal stromal cell extracellular vesicles.
2024;84:1115-1132. Cytotherapy. 2022;25:502-509.
doi: 10.1158/0008-5472.CAN-23-2504 doi: 10.1016/j.jcyt.2022.11.006
56. Parte S, Kaur AB, Nimmakayala RK, et al. Cancer-associated 65. Wang S, Leu B, Zhang E, et al. Targeted therapy for
fibroblast induces acinar-to-ductal cell transdifferentiation inflammatory diseases with mesenchymal stem cells
and pancreatic cancer initiation Via LAMA5/ITGA4 axis. and their derived exosomes: from basic to clinics. Int J
Gastroenterology. 2023;166:842-858.e5. Nanomedicine. 2022;17:1757-1781.
doi: 10.1053/j.gastro.2023.12.018 doi: 10.2147/IJN.S355366
57. Zhou Y, Zhou W, Chen X, et al. Bone marrow mesenchymal 66. Zhang L, Ma XJ, Fei YY, et al. Stem cell therapy in liver
stem cells-derived exosomes for penetrating and targeted regeneration: Focus on mesenchymal stem cells and induced
chemotherapy of pancreatic cancer. Acta Pharm Sin B. pluripotent stem cells. Pharmacol Ther. 2021;232:108004.
2020;10:1563-1575. doi: 10.1016/j.pharmthera.2021.108004
doi: 10.1016/j.apsb.2019.11.013 67. Zhang J, Guan J, Niu X, et al. Exosomes released from human
58. Zhou W, Zhou Y, Chen X, et al. Pancreatic cancer- induced pluripotent stem cells-derived MSCs facilitate
targeting exosomes for enhancing immunotherapy and cutaneous wound healing by promoting collagen synthesis
reprogramming tumor microenvironment. Biomaterials. and angiogenesis. J Transl Med. 2015;13:49.
2020;268:120546. doi: 10.1186/s12967-015-0417-0
doi: 10.1016/j.biomaterials.2020.120546 68. Kim S, Lee SK, Kim H, Kim TM. Exosomes secreted from
59. He Z, Li W, Zheng T, Liu D, Zhao S. Human umbilical induced pluripotent stem cell-derived mesenchymal
cord mesenchymal stem cells-derived exosomes deliver stem cells accelerate skin cell proliferation. Int J Mol Sci.
microRNA-375 to downregulate ENAH and thus retard 2018;19:3119.
esophageal squamous cell carcinoma progression. J Exp Clin doi: 10.3390/ijms19103119
Cancer Res. 2020;39:59.
69. Wei Y, Hou H, Zhang L, et al. JNKi-and DAC-programmed
doi: 10.1186/s13046-020-01631-w mesenchymal stem/stromal cells from hESCs facilitate
60. Li N, Wang B. Suppressive effects of umbilical cord hematopoiesis and alleviate hind limb ischemia. Stem Cell
mesenchymal stem cell-derived exosomal miR-15a-5p Res Ther. 2019;10:186.
on the progression of cholangiocarcinoma by inhibiting doi: 10.1186/s13287-019-1302-1
CHEK1 expression. Cell Death Discov. 2022;8:205.
70. Zhou H, Zhu L, Song J, et al. Liquid biopsy at the frontier
doi: 10.1038/s41420-022-00932-7 of detection, prognosis and progression monitoring in
61. Zou J, Yang W, Cui W, et al. Therapeutic potential colorectal cancer. Mol Cancer. 2022;21:86.
and mechanisms of mesenchymal stem cell-derived doi: 10.1186/s12943-022-01556-2
exosomes as bioactive materials in tendon-bone healing.
J Nanobiotechnol. 2023;21:14. 71. Xia Y, Sun Y, Liu Y, et al. Targeted delivery of RGD-CD146(+)
CD271(+) human umbilical cord mesenchymal stem cell-
doi: 10.1186/s12951-023-01778-6 derived exosomes promotes blood-spinal cord barrier repair
after spinal cord injury. ACS Nano. 2023;17:18008-18024.
62. Popowski K, Lutz H, Hu S, et al. Exosome therapeutics
for lung regenerative medicine. J Extracell Vesicles. doi: 10.1021/acsnano.3c04423
2020;9:1785161.
72. Phan J, Kumar P, Hao D, Gao K, Farmer D, Wang A.
doi: 10.1080/20013078.2020.1785161 Engineering mesenchymal stem cells to improve their
exosome efficacy and yield for cell-free therapy. J Extracell
63. Huang R, Bo Jia 2, Dandan Su, et al. Plant exosomes
fused with engineered mesenchymal stem cell-derived Vesicles. 2018;7(1):1522236.
nanovesicles for synergistic therapy of autoimmune skin doi: 10.1080/20013078.2018.1522236
Volume 2 Issue 3 (2025) 12 doi: 10.36922/IMO025210025

